Chitra Sridar

SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES

Chitra Sridar, Theunis C. Goosen, Ute M. Kent et al. · Drug Metabolism and Disposition · 2004 · 192 citations

The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6

Natasha T. Snider, Matthew J. Sikora, Chitra Sridar et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 103 citations · Full text

Effect of Tamoxifen on the Enzymatic Activity of Human Cytochrome CYP2B6

Chitra Sridar, Ute M. Kent, L. Notley et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 69 citations

Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4–CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex

Haoming Zhang, Chitra Sridar, Cesar Kenaan et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 63 citations · Full text

Anandamide Oxidation by Wild-Type and Polymorphically Expressed CYP2B6 and CYP2D6

Chitra Sridar, Natasha T. Snider, Paul F. Hollenberg · Drug Metabolism and Disposition · 2011 · 54 citations · Full text